Cargando…
H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies
BACKGROUND: Schistosomiasis is a socioeconomically devastating parasitic infection afflicting hundreds of millions of people and animals worldwide. It is the most important helminth infection, and its treatment relies solely on the drug praziquantel. Oral H1-antihistamines are available worldwide, a...
Autores principales: | Xavier, Rogério P., Mengarda, Ana C., Silva, Marcos P., Roquini, Daniel B., Salvadori, Maria C., Teixeira, Fernanda S., Pinto, Pedro L., Morais, Thiago R., Ferreira, Leonardo L. G., Andricopulo, Adriano D., de Moraes, Josué |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268501/ https://www.ncbi.nlm.nih.gov/pubmed/32487175 http://dx.doi.org/10.1186/s13071-020-04140-z |
Ejemplares similares
-
The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets
por: Roquini, Vinícius, et al.
Publicado: (2023) -
Pyrazoline derivatives as promising novel antischistosomal agents
por: Morais, Cristiane S., et al.
Publicado: (2021) -
Antischistosomal Activity of the Terpene Nerolidol
por: Silva, Marcos P.N., et al.
Publicado: (2014) -
Susceptibility of Angiostrongylus cantonensis Larvae to Anthelmintic Drugs
por: Roquini, Daniel B., et al.
Publicado: (2022) -
Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds
por: Pavani, Thaís F. A., et al.
Publicado: (2023)